COMPANY

IDBiologics, Inc.

HQ: Nashville, TN source · idbiologics.com ↗ · Southeast

Also known as IDBiologics · 5 sources

IDBiologics has a panel of anti-BKV mAbs, including a lead and back-up clinical candidates that are being developed as a prevention of BKV viremia / DNAemia and BKVAN. IDBiologics has two human monoclonal antibodies that directly inhibit RVFV replication, do not bind to the same critical residues, and have been engineered with an extended half-life for combination use. From company website Source · Oct 12, 2026

Keywords: monoclonal antibodies

Location: Nashville, TN · source · Oct 15, 2026

Profile checked Oct 10, 2026

5NIH grants

NIH awards 5

Annual award amounts. Total $2.5M.

2023 NIH contract (government contract; not a grant and not an investment round) 75N93020C00027-P00004-9999-1 FY2023: $113,583 awarded for that fiscal year; activity N01 (OTHER_NIH); PI HAINES, CHARLES; recipient as written: IDBIOLOGICS, LLC, NASHVILLE, TN. Monoclo source ↗
2021 NIH contract (government contract; not a grant and not an investment round) 75N93020C00027-P00002-9999-1 FY2021: $1,499,394 awarded for that fiscal year; activity N01 (OTHER_NIH); PI HAINES, CHARLES; recipient as written: IDBIOLOGICS, LLC, NASHVILLE, TN. Monoc source ↗
2020 NIH contract (government contract; not a grant and not an investment round) 75N93020C00027-0-9999-1 FY2020: $298,671 awarded for that fiscal year; activity N01 (OTHER_NIH); PI HAINES, CHARLES; recipient as written: IDBIOLOGICS, LLC, NASHVILLE, TN. Monoclonal a source ↗
Sep 5, 2019 NIH award 1R41AI140945-01A1 FY2019: $300,000 awarded for that fiscal year; activity R41 (STTR); PI HAINES, CHARLES F; recipient as written: IDBIOLOGICS, LLC, NASHVILLE, TN. Fully Human Antibodies for the Prevention o source ↗
Aug 14, 2019 NIH award 1R41AI148019-01 FY2019: $294,700 awarded for that fiscal year; activity R41 (STTR); PI HAINES, CHARLES F; recipient as written: IDBIOLOGICS, LLC, NASHVILLE, TN. Fully Human Antibody Combinations for the Pre source ↗